Close Menu

NEW YORK – NanoString Technologies reported after the close of the market on Monday that its third quarter revenues were up 4 percent year over year.

For the three months ended Sept. 30, NanoString's revenues were $31.8 million, compared to $30.6 million in Q3 2019, beating the Wall Street estimate of $28.7 million.

The Seattle-based firm said it took in $30.1 million in product and service revenue, up 14 percent from $26.3 million in Q3 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.